147 related articles for article (PubMed ID: 38106277)
1. Multisequence MRI-based radiomics analysis for early prediction of the risk of T790M resistance in new brain metastases.
Lv X; Li Y; Wang B; Wang Y; Pan Y; Li C; Hou D
Quant Imaging Med Surg; 2023 Dec; 13(12):8599-8610. PubMed ID: 38106277
[TBL] [Abstract][Full Text] [Related]
2. Predicting EGFR T790M Mutation in Brain Metastases Using Multisequence MRI-Based Radiomics Signature.
Li Y; Lv X; Wang B; Xu Z; Wang Y; Sun M; Hou D
Acad Radiol; 2023 Sep; 30(9):1887-1895. PubMed ID: 36586758
[TBL] [Abstract][Full Text] [Related]
3. Multisequence MRI-based radiomics nomogram for early prediction of osimertinib resistance in patients with non-small cell lung cancer brain metastases.
Lv X; Li Y; Xu X; Zheng Z; Li F; Fang K; Wang Y; Wang B; Hou D
Eur J Radiol Open; 2023 Dec; 11():100521. PubMed ID: 37692549
[TBL] [Abstract][Full Text] [Related]
4. Multisequence MRI-based radiomics signature as potential biomarkers for differentiating KRAS mutations in non-small cell lung cancer with brain metastases.
Lv X; Li Y; Wang B; Wang Y; Xu Z; Hou D
Eur J Radiol Open; 2024 Jun; 12():100548. PubMed ID: 38298532
[TBL] [Abstract][Full Text] [Related]
5. Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis.
Li Y; Lv X; Wang B; Xu Z; Wang Y; Gao S; Hou D
Eur J Radiol; 2022 Oct; 155():110499. PubMed ID: 36049410
[TBL] [Abstract][Full Text] [Related]
6. A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.
Li Y; Lv X; Chen C; Yu R; Wang B; Wang D; Hou D
Eur Radiol Exp; 2024 Jan; 8(1):2. PubMed ID: 38169047
[TBL] [Abstract][Full Text] [Related]
7. Preoperative MRI-Based Radiomics of Brain Metastasis to Assess T790M Resistance Mutation After EGFR-TKI Treatment in NSCLC.
Fan Y; He L; Yang H; Wang Y; Su J; Hou S; Luo Y; Jiang X
J Magn Reson Imaging; 2023 Jun; 57(6):1778-1787. PubMed ID: 36165534
[TBL] [Abstract][Full Text] [Related]
8. CT-based nomogram for early identification of T790M resistance in metastatic non-small cell lung cancer before first-line epidermal growth factor receptor-tyrosine kinase inhibitors therapy.
Li Y; Lv X; Wang Y; Xu Z; Lv Y; Hou D
Eur Radiol Exp; 2023 Nov; 7(1):64. PubMed ID: 37914925
[TBL] [Abstract][Full Text] [Related]
9. Brain-Tumor Interface-Based MRI Radiomics Models to Determine EGFR Mutation, Response to EGFR-TKI and T790M Resistance Mutation in Non-Small Cell Lung Carcinoma Brain Metastasis.
Fan Y; Wang X; Yang C; Chen H; Wang H; Wang X; Hou S; Wang L; Luo Y; Sha X; Yang H; Yu T; Jiang X
J Magn Reson Imaging; 2023 Dec; 58(6):1838-1847. PubMed ID: 37144750
[TBL] [Abstract][Full Text] [Related]
10. Radiomics signature of brain metastasis: prediction of EGFR mutation status.
Wang G; Wang B; Wang Z; Li W; Xiu J; Liu Z; Han M
Eur Radiol; 2021 Jul; 31(7):4538-4547. PubMed ID: 33439315
[TBL] [Abstract][Full Text] [Related]
11. Radiomics Based on T2-Weighted Imaging and Apparent Diffusion Coefficient Images for Preoperative Evaluation of Lymph Node Metastasis in Rectal Cancer Patients.
Li C; Yin J
Front Oncol; 2021; 11():671354. PubMed ID: 34041033
[TBL] [Abstract][Full Text] [Related]
12. Applying multisequence MRI radiomics of the primary tumor and lymph node to predict HPV-related p16 status in patients with oropharyngeal squamous cell carcinoma.
Li Q; Xu T; Gong J; Xiang S; Shen C; Zhou X; Hu C; Wu B; Lu X
Quant Imaging Med Surg; 2023 Apr; 13(4):2234-2247. PubMed ID: 37064405
[TBL] [Abstract][Full Text] [Related]
13. MR-based radiomics predictive modelling of EGFR mutation and HER2 overexpression in metastatic brain adenocarcinoma: a two-centre study.
Li Y; Jin Y; Wang Y; Liu W; Jia W; Wang J
Cancer Imaging; 2024 May; 24(1):65. PubMed ID: 38773634
[TBL] [Abstract][Full Text] [Related]
14. Development and external validation of a multiparametric MRI-based radiomics model for preoperative prediction of microsatellite instability status in rectal cancer: a retrospective multicenter study.
Li Z; Zhang J; Zhong Q; Feng Z; Shi Y; Xu L; Zhang R; Yu F; Lv B; Yang T; Huang C; Cui F; Chen F
Eur Radiol; 2023 Mar; 33(3):1835-1843. PubMed ID: 36282309
[TBL] [Abstract][Full Text] [Related]
15. Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study.
Wang H; Xu X; Zhang X; Liu Y; Ouyang L; Du P; Li S; Tian Q; Ling J; Guo Y; Lu H
Eur Radiol; 2020 Sep; 30(9):4816-4827. PubMed ID: 32318846
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Prediction of Lymph Node Metastasis of Pancreatic Ductal Adenocarcinoma Based on a Radiomics Nomogram of Dual-Parametric MRI Imaging.
Shi L; Wang L; Wu C; Wei Y; Zhang Y; Chen J
Front Oncol; 2022; 12():927077. PubMed ID: 35875061
[TBL] [Abstract][Full Text] [Related]
17. Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma.
Fan Y; Dong Y; Wang H; Wang H; Sun X; Wang X; Zhao P; Luo Y; Jiang X
Eur Radiol; 2022 Oct; 32(10):6739-6751. PubMed ID: 35729427
[TBL] [Abstract][Full Text] [Related]
18. MRI-based radiomics analysis to predict preoperative lymph node metastasis in papillary thyroid carcinoma.
Hu W; Wang H; Wei R; Wang L; Dai Z; Duan S; Ge Y; Wu PY; Song B
Gland Surg; 2020 Oct; 9(5):1214-1226. PubMed ID: 33224796
[TBL] [Abstract][Full Text] [Related]
19. Clinical Breast MRI-based Radiomics for Distinguishing Benign and Malignant Lesions: An Analysis of Sequences and Enhanced Phases.
Wang G; Guo Q; Shi D; Zhai H; Luo W; Zhang H; Ren Z; Yan G; Ren K
J Magn Reson Imaging; 2023 Nov; ():. PubMed ID: 38006286
[TBL] [Abstract][Full Text] [Related]
20. An Integrated Radiomics Model Incorporating Diffusion-Weighted Imaging and
Zhang L; Yao R; Gao J; Tan D; Yang X; Wen M; Wang J; Xie X; Liao R; Tang Y; Chen S; Li Y
Front Oncol; 2021; 11():732704. PubMed ID: 34527594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
